Companies / Argentina
Wider Participation In Vaccine Sector?
December 2007 | Company News AlertA research collaboration has been announced between the UK's PepTcell and Argentina's Gador S.A. that hopes to develop a vaccine against Chagas disease. Under the collaboration, PepTcell will develop the vaccine and conduct early phase clinical trials. Once the vaccine enters phase III trials, Gator, with its knowledge of the Argentinean drug market would assume responsibility for the final stages of testing, commercialisation and
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
